Intensity Therapeutics Files 8-K
Ticker: INTS · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1567264
| Field | Detail |
|---|---|
| Company | Intensity Therapeutics, Inc. (INTS) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-disclosure, financial-statements
TL;DR
INTENSITY THERAPEUTICS FILED AN 8-K - REG FD DISCLOSURE & FINANCIALS
AI Summary
Intensity Therapeutics, Inc. filed an 8-K on April 23, 2025, reporting an event on April 22, 2025. The filing is primarily a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific material events or financial figures were detailed in the provided text excerpt.
Why It Matters
This 8-K filing indicates that Intensity Therapeutics, Inc. has made a regulatory disclosure and submitted financial statements, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Players & Entities
- INTENSITY THERAPEUTICS, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 001-41109 (company_id) — Commission File Number
- 46-1488089 (company_id) — IRS Employer Identification No.
- 1 Enterprise Drive, Suite 430 Shelton, CT 06484-4779 (address) — Principal Executive Offices
- 203-221-7381 (phone_number) — Registrant's Telephone Number
- April 22, 2025 (date) — Date of earliest event reported
- April 23, 2025 (date) — Date of Report
FAQ
What specific event triggered this 8-K filing on April 22, 2025?
The provided excerpt does not specify the exact event that triggered the 8-K filing on April 22, 2025, only that it was a Regulation FD Disclosure and included Financial Statements and Exhibits.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to serve as a Current Report, specifically for a Regulation FD Disclosure and to include Financial Statements and Exhibits.
Where are Intensity Therapeutics, Inc.'s principal executive offices located?
Intensity Therapeutics, Inc.'s principal executive offices are located at 1 Enterprise Drive, Suite 430, Shelton, CT 06484-4779.
What is the Commission File Number for Intensity Therapeutics, Inc.?
The Commission File Number for Intensity Therapeutics, Inc. is 001-41109.
What is the SIC code for Intensity Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Intensity Therapeutics, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding INTENSITY THERAPEUTICS, INC. (INTS).